Glycolysis inhibition can be particularly effective against cancer cells with a mitochondrial defect or in hypoxic conditions, and the CD47 pathway can also work as a “don’t eat me” signal to macrophage cells, promoting immune escape in certain types of cancer [76,77]. This evidence concerns the gene CD47 and cancer.